News Conference News VIVA 2025 ENGULF Novel PE Thrombectomy Device Minimizes Blood Loss L.A. McKeown November 07, 2025
News Conference News ESC 2025 Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD L.A. McKeown September 05, 2025
News Conference News ACC 2025 Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT Caitlin E. Cox March 29, 2025
News Conference News ESC 2023 ONCO DVT Supports 12 Months of Preventive DOACs in Cancer Patients L.A. McKeown August 30, 2023
News Conference News ISET 2023 ‘Who’s In Charge of a Wound?’: Interventionalists Should Play a Role Caitlin E. Cox January 18, 2023
News Conference News ISET 2023 For Vascular Labs, Accreditation Drives Quality and Objectivity Caitlin E. Cox January 17, 2023
News Conference News ACC 2021 SAFE-PAD Throws More Doubt on the Paclitaxel Mortality Signal L.A. McKeown May 16, 2021
News Conference News ISET 2020 PAD Care on the Backdrop of Cancer Requires Creativity, Persistence Caitlin E. Cox January 23, 2020
News Conference News VEITH 2019 More Real-world Data Support Safety of Paclitaxel-Based Devices in PAD L.A. McKeown November 22, 2019
News Conference News VIVA 2019 Clinicians Get Real on Radiation: ‘Don’t Do Dumb Things’ L.A. McKeown November 07, 2019
News Conference News TCT 2019 LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD L.A. McKeown September 28, 2019
News Conference News CRT 2019 Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy L.A. McKeown March 06, 2019
News Conference News ISET 2018 ‘Bioconvertible’ IVC Filter Does Its Job Then Moves On: SENTRY Trial Caitlin E. Cox February 15, 2018
News Conference News ESC 2017 VIVA: Could Population-Wide Screening Trial for AAA, PAD, and Hypertension Save Lives at Low Cost? Shelley Wood August 28, 2017
News Conference News ISET 2017 Underappreciated by Clinicians, Critical Limb Ischemia Has Dire Fallout for Patients Caitlin E. Cox February 07, 2017